A comprehensive view of U.S. Food and Drug Administration (FDA). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
AFFI hosts Food Safety Forum on FDA's chemical safety approach; opens registration for AFFI-CON 2025 to advance frozen food industry collaboration
Published:
September 19, 2024
by Industry Intelligence Inc.
|
3D Systems gains FDA clearance for multi-material, monolithic jetted denture solution; innovation aims to enhance automation, profitability in dental prosthetics manufacturing
Published:
September 18, 2024
by Industry Intelligence Inc.
|
FDA approves Merck's KEYTRUDA with chemotherapy for advanced mesothelioma; treatment shows 21% reduction in death risk versus chemotherapy alone in Phase 3 trial
Published:
September 18, 2024
by Merck & Co. Inc.
|
AstraZeneca's Fasenra approved in US for eosinophilic granulomatosis with polyangiitis; MANDARA trial shows 60% of patients achieved remission, 41% stopped oral corticosteroids
Published:
September 18, 2024
by AstraZeneca AB
|
Reagan-Udall Foundation will hold public meeting on Oct. 7, to hear insights about Final Rule on Requirements for Additional Traceability Records from both FDA leadership and experts across food industry sectors
Published:
September 17, 2024
by States News Service
|
Ask us about our Tissue & Hygiene market view